What Works

Narrow Your Results

Strategy

Works (2)
Promising (1)
Gap (5)

Sections

Malaria (8)

Keywords

treatment (3)
malaria (3)
pregnancy (1)
screening (1)
PCR (1)
bednets (1)

Places

Gray Ratings

Gray IIIa (3)
Gray I (2)
Gray II (2)
Gray IV (1)
Gray V (1)

Showing 1 - 8 of 8 Results for "malaria"

Results

Further research is needed on infant transmission risks of malaria and/or HIV in pregnant women who have malaria-HIV co-infection.

1 study

Intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine (SP) is effective in preventing malaria and decreasing prevalence of anemia among pregnant women with HIV.

4 studies Gray I, II, IIIa malaria, treatment Malawi, Mozambique

Co-trimoxazole prophylaxis, antiretroviral therapy and ITNs can substantially reduce the incidence of malaria in women living with HIV.

4 studies Gray I, II, IIIa, V bednets, malaria, treatment Africa, Rwanda, Thailand, Uganda

PCR has a higher sensitivity than blood-smear microscopy to detect malaria co-infection in HIV-positive and HIV-negative pregnant women.

2 studies Gray IIIa, IV PCR, malaria, pregnancy, screening, treatment Democratic Republic of Congo, Kenya

Young women, in particular, need access to services and treatment for HIV and malaria during the perinatal period because they are more likely to be pregnant for the first time.

1 study

Further studies are needed to determine whether standard intermittent preventive treatment and antiretroviral therapy regimens are medically and operationally compatible in pregnancy and to determine safe and effective protocols for management of concurrent HIV and malarial infections in pregnant and non-pregnant women living with HIV. A study found that alternative malarial drug regimens should be considered for HIV/malaria co-infected patients receiving nevirapine.

1 study

Alternate efficacious drugs for intermittent preventive treatment are needed due to resistance to SP. In Tanzania, a country with high rates of SP resistance, SP during pregnancy increased the risk of fetal anemia and decreased cord hemoglobin levels. IPTp did not decrease the risk of placental malaria, maternal anemia, or low birth weight. (Harrington et al., 2011).

1 study

Additional efforts are needed to reduce HIV stigma so that women will present at health care settings with malaria symptoms and be willing to test for HIV before the development of more serious complications.

1 study